Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Queen's University Ferring Pharmaceuticals |
---|---|
Information provided by: | Queen's University |
ClinicalTrials.gov Identifier: | NCT00885430 |
Twenty adult volunteers will be administered Pico-Salax in the usual fashion for colonoscopy with intense monitoring of serum and urine chemistry and hemodynamics.
Condition | Intervention | Phase |
---|---|---|
Hemodynamics Hyponatremia |
Drug: Pico-Salax |
Phase IV |
Study Type: | Interventional |
Study Design: | Diagnostic, Open Label, Uncontrolled, Single Group Assignment, Safety Study |
Official Title: | Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes |
Enrollment: | 20 |
Study Start Date: | July 2008 |
Study Completion Date: | September 2008 |
Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Pico-Salax: Experimental |
Drug: Pico-Salax
Two sachets of Pico-Salax given 5 hours apart
|
Ages Eligible for Study: | 45 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Canada, Ontario | |
Hotel Dieu Hospital | |
Kingston, Ontario, Canada, K7L5G2 |
Principal Investigator: | Lawrence Hookey, MD | Queen's University |
Responsible Party: | Queen's University ( Lawrence Hookey, MD ) |
Study ID Numbers: | Hookey Pico-Salax Volunteers |
Study First Received: | April 20, 2009 |
Last Updated: | April 21, 2009 |
ClinicalTrials.gov Identifier: | NCT00885430 History of Changes |
Health Authority: | Canada: Health Canada |
colonoscopy preparation |
Metabolic Diseases Hyponatremia Water-Electrolyte Imbalance Metabolic Disorder |
Metabolic Diseases Hyponatremia Water-Electrolyte Imbalance |